Vis enkel innførsel

dc.contributor.authorWallstrom, Tove
dc.contributor.authorJärnbert-Pettersson, Hans
dc.contributor.authorStenson, David
dc.contributor.authorAkerud, Helena
dc.contributor.authorDarj, Elisabeth
dc.contributor.authorGemzell-Danielsson, Kristina
dc.contributor.authorWiberg-Itzel, Eva
dc.date.accessioned2018-08-22T07:42:43Z
dc.date.available2018-08-22T07:42:43Z
dc.date.created2018-01-08T13:45:33Z
dc.date.issued2017
dc.identifier.issn2314-6133
dc.identifier.urihttp://hdl.handle.net/11250/2558777
dc.description.abstractIntroduction. One great challenge in obstetric care is labor inductions. Misoprostol has advantages in being cheap and stable at room temperature and available in resource-poor settings. Material and Methods. Retrospective cohort study of 4002 singleton pregnancies with a gestational age ≥34 w at Sodersjukhuset, Stockholm, during 2009-2010 and 2012-2013. Previously used methods of labor induction were compared with misoprostol given as a solution to drink, every second hour. Main outcome is as follows: Cesarean Section (CS) rate, acid-base status in cord blood, Apgar score < 7,5𸀠�� , active time of labor, and blood loss > 1500 ml (PPH). Results. The proportion of CS decreased from 26% to 17% when orally given solution of misoprostol was introduced at the clinic (𝑝�� < 0.001). No significant difference in the frequency of low Apgar score (𝑝�� = 0.3), low aPh in cord blood (𝑝�� = 0.1), or PPH (𝑝�� = 0.4) between the different methods of induction was studied. After adjustment for different risk factor for CS the only method of induction which was associated with CS was dinoproston∗∗ (Propess) (aor = 2.9 (1.6–5.2)). Conclusion. Induction of labor with misoprostol, given as an oral solution to drink every second hour, gives a low rate of CS, without affecting maternal or fetal outcomenb_NO
dc.language.isoengnb_NO
dc.publisherHindawi Publishing Corporationnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleLabor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.volume2017nb_NO
dc.source.journalBioMed Research Internationalnb_NO
dc.identifier.doi10.1155/2017/6840592
dc.identifier.cristin1537774
dc.description.localcodeCopyright © 2017 Tove Wallstrom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citednb_NO
cristin.unitcode194,65,20,0
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal